Life Science Consulting
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
55
NCT02426541
Effects of Dapagliflozin 10 mg on Insulin Resistance in Patients With Type 2 Diabetes Mellitus
Phase: Phase 4
Role: Collaborator
Start: Mar 23, 2015
Completion: Apr 28, 2016
Loading map...